Clinical Trial Update: Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL） [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pemetrexed plus temozolomide in relapsed primary central nervous system lymphoma. The current status of the trial is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• Alimta (pemetrexed)
• Temodar (Temozolomide)

Snippet

Sponsor: Rongjie Tao | Conditions: Central Nervous System Tumors | Phase 2 | Status: UNKNOWN